Literature DB >> 12727882

Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein.

Alessandro Marcello1, Aldo Ferrari, Vittorio Pellegrini, Gianluca Pegoraro, Marina Lusic, Fabio Beltram, Mauro Giacca.   

Abstract

Human cyclin T1, the cyclin partner of Cdk9 kinase in the positive transcription elongation factor b (P-TEFb), is an essential cellular cofactor that is recruited by the human immunodeficiency virus type 1 (HIV-1) Tat transactivator to promote transcriptional elongation from the HIV-1 long terminal repeat (LTR). Here we exploit fluorescence resonance energy transfer (FRET) to demonstrate that cyclin T1 physically interacts in vivo with the promyelocytic leukaemia (PML) protein within specific subnuclear compartments that are coincident with PML nuclear bodies. Deletion mutants at the C-terminal region of cyclin T1 are negative for FRET with PML and fail to localize to nuclear bodies. Cyclin T1 and PML are also found associated outside of nuclear bodies, and both proteins are present at the chromatinized HIV-1 LTR promoter upon Tat transactivation. Taken together these results suggest that PML proteins regulate Tat- mediated transcriptional activation by modulating the availability of cyclin T1 and other essential cofactors to the transcription machinery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12727882      PMCID: PMC156077          DOI: 10.1093/emboj/cdg205

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  54 in total

1.  Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome.

Authors:  L Zentilin; A Marcello; M Giacca
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

Review 2.  Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins.

Authors:  Peter van Roessel; Andrea H Brand
Journal:  Nat Cell Biol       Date:  2002-01       Impact factor: 28.824

3.  Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes.

Authors:  Ran Taube; Xin Lin; Dan Irwin; Koh Fujinaga; B Matija Peterlin
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

Review 4.  The renaissance of fluorescence resonance energy transfer.

Authors:  P R Selvin
Journal:  Nat Struct Biol       Date:  2000-09

5.  Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus.

Authors:  Masafumi Muratani; Daniel Gerlich; Susan M Janicki; Matthias Gebhard; Roland Eils; David L Spector
Journal:  Nat Cell Biol       Date:  2002-02       Impact factor: 28.824

6.  7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes.

Authors:  V T Nguyen; T Kiss; A A Michels; O Bensaude
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

7.  The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription.

Authors:  Z Yang; Q Zhu; K Luo; Q Zhou
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

8.  c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism.

Authors:  S R Eberhardy; P J Farnham
Journal:  J Biol Chem       Date:  2001-10-22       Impact factor: 5.157

Review 9.  DNA viruses and viral proteins that interact with PML nuclear bodies.

Authors:  R D Everett
Journal:  Oncogene       Date:  2001-10-29       Impact factor: 9.867

10.  PML bodies associate specifically with the MHC gene cluster in interphase nuclei.

Authors:  C Shiels; S A Islam; R Vatcheva; P Sasieni; M J Sternberg; P S Freemont; D Sheer
Journal:  J Cell Sci       Date:  2001-10       Impact factor: 5.285

View more
  31 in total

1.  Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter.

Authors:  Marina Lusic; Alessandro Marcello; Anna Cereseto; Mauro Giacca
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

2.  Development of a novel GFP-based ratiometric excitation and emission pH indicator for intracellular studies.

Authors:  Ranieri Bizzarri; Caterina Arcangeli; Daniele Arosio; Fernanda Ricci; Paolo Faraci; Francesco Cardarelli; Fabio Beltram
Journal:  Biophys J       Date:  2006-05-01       Impact factor: 4.033

Review 3.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

4.  Primitive hematopoietic cells resist HIV-1 infection via p21.

Authors:  Jielin Zhang; David T Scadden; Clyde S Crumpacker
Journal:  J Clin Invest       Date:  2007-02       Impact factor: 14.808

5.  Nuclear positional control of HIV transcription in 4D.

Authors:  Alessandro Marcello; Somdutta Dhir; Mariacarolina Dieudonné
Journal:  Nucleus       Date:  2010 Jan-Feb       Impact factor: 4.197

6.  p53-derived host restriction of HIV-1 replication by protein kinase R-mediated Tat phosphorylation and inactivation.

Authors:  Cheol-Hee Yoon; Sang-Yoon Kim; Se Eun Byeon; Yideul Jeong; Jinjoo Lee; Kwang Pyo Kim; Jinseu Park; Yong-Soo Bae
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

Review 7.  Underlying mechanisms of HIV-1 latency.

Authors:  Bizhan Romani; Elham Allahbakhshi
Journal:  Virus Genes       Date:  2017-03-03       Impact factor: 2.332

Review 8.  Understanding HIV latency: the road to an HIV cure.

Authors:  Matthew S Dahabieh; Emilie Battivelli; Eric Verdin
Journal:  Annu Rev Med       Date:  2015       Impact factor: 13.739

Review 9.  Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.

Authors:  Laurence Colin; Carine Van Lint
Journal:  Retrovirology       Date:  2009-12-04       Impact factor: 4.602

10.  Interaction of the retinoblastoma protein with Orc1 and its recruitment to human origins of DNA replication.

Authors:  Ramiro Mendoza-Maldonado; Roberta Paolinelli; Laura Galbiati; Sara Giadrossi; Mauro Giacca
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.